Silence Therapeutics Plc SLN shares are up during Friday’s session. On Thursday, the company highlighted follow-up data from ...
Silence Therapeutics plc (Nasdaq: SLN), a global clinical-stage biotechnology company developing novel siRNA (short ...
Silence Therapeutics plc Buy: siRNA progress in PV & ASCVD, divesiran SANRECO data and Aug 2026 catalyst; watch cash ...
Detailed price information for Silence Therapeutics Plc ADR (SLN-Q) from The Globe and Mail including charting and trades.
View Silence Therapeutics PLC Sponsored ADR SLN stock quote prices, financial information, real-time forecasts, and company news from CNN.
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results